Post-polycythemia Myelofibrosis
📧 Sign up to get email alerts when something new happens for Post-polycythemia Myelofibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis [Phase 2]
Phase 2 clinical trial evaluating LCL161 in patients with various forms of myelofibrosis has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: LBH589 (Panobinostat) for the Treatment of Myelofibrosis [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update for LBH589 (panobinostat) in myelofibrosis with current status not reported.